Noxafil
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
| Name | Noxafil |
|---|---|
| Active Substance | posakonazol |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept (oralna suspenzija, želučanootporna tableta, koncentrat za otopinu za infuziju) |
| Distribution | Supply through pharmacies (community) |
| ATC Code | J02AC04 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
| Link to the European Medicines Agency's (EMA) product information | download |
| Link to the European Commission's (EC) decisions | download |
Packaging
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o međusobnoj nezamjenjivosti tablete i oralne otopine lijeka Noxafil (posakonazol) | 24.08.2016 | Merck Sharp & Dohme Limited |
